Todd K. Rosengart

Todd K. Rosengart (born January 24, 1960) is an American cardiothoracic surgeon, educator, and researcher, currently serving as the Chair of the Michael E. DeBakey Department of Surgery and Vice President for Hospital Operations and Quality Improvements at Baylor College of Medicine (BCM). In addition, he serves as the DeBakey-Bard Chair and professor of heart and vascular disease at the Texas Heart Institute. He has been a leading researcher in cardiac angiogenesis and regeneration and is known for performing the world's first viral-based gene cardiac transfer procedure. and for his contributions to medical education and technology entrepreneurship. Rosengart is recognized for his expertise in procedures such as bypass surgery, valve repair, minimally invasive surgery and heart transplantation Provided by Wikipedia
Showing 1 - 11 results of 11 for search 'Todd K. Rosengart', query time: 0.05s Refine Results
  1. 1
    Activation of a GPCR, ORL1 Receptor: A Novel Therapy to Prevent Heart Failure Progression

    Activation of a GPCR, ORL1 Receptor: A Novel Therapy to Prevent Heart Failure Progression by Saliha S. Pathan, Aarthi Pugazenthi, Beverly R. E. A. Dixon, Theodore G. Wensel, Todd K. Rosengart, Megumi Mathison

    Published 2024-11-01
    Get full text
    Article
  2. 2
    Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming

    Hippo Pathway Effector Tead1 Induces Cardiac Fibroblast to Cardiomyocyte Reprogramming by Vivek P. Singh, Jaya P. Pinnamaneni, Aarthi Pugazenthi, Deepthi Sanagasetti, Megumi Mathison, James F. Martin, Jianchang Yang, Todd K. Rosengart

    Published 2021-12-01
    Get full text
    Article
  3. 3
    Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential

    Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential by Hong Gao, Saliha Pathan, Beverly R. E. A. Dixon, Aarthi Pugazenthi, Megumi Mathison, Tamer M.A. Mohamed, Todd K. Rosengart, Jianchang Yang

    Published 2024-10-01
    Get full text
    Article
  4. 4
    Minimally Invasive Mitral Valve Surgery Using a Cold Fibrillatory Cardiac Arrest Technique in Patients With Prior Cardiac Surgery

    Minimally Invasive Mitral Valve Surgery Using a Cold Fibrillatory Cardiac Arrest Technique in Patients With Prior Cardiac Surgery by Ahmed Ali, MD, Zachary Gray, PA-C, Gabriel Loor, MD, Alexis E. Shafii, MD, Todd K. Rosengart, MD, Kenneth K. Liao, MD, PhD

    Published 2024-07-01
    Get full text
    Article
  5. 5
    Prolonged Cardiopulmonary Bypass Time-Induced Endothelial Dysfunction via Glypican-1 Shedding, Inflammation, and Matrix Metalloproteinase 9 in Patients Undergoing Cardiac Surgery

    Prolonged Cardiopulmonary Bypass Time-Induced Endothelial Dysfunction via Glypican-1 Shedding, Inflammation, and Matrix Metalloproteinase 9 in Patients Undergoing Cardiac Surgery by Shiyi Li, Katherine V. Nordick, Iván Murrieta-Álvarez, Randall P. Kirby, Rishav Bhattacharya, Ismael Garcia, Camila Hochman-Mendez, Todd K. Rosengart, Kenneth K. Liao, Nandan K. Mondal

    Published 2024-12-01
    Get full text
    Article
  6. 6
    Outcomes after bioprosthetic versus mechanical mitral valve replacement for infective endocarditis in the United StatesCentral MessagePerspective

    Outcomes after bioprosthetic versus mechanical mitral valve replacement for infective endocarditis in the United StatesCentral MessagePerspective by Katie J. Hogan, BS, Christopher B. Sylvester, MD, PhD, Matthew J. Wall, Jr., MD, Todd K. Rosengart, MD, Joseph S. Coselli, MD, Marc R. Moon, MD, Subhasis Chatterjee, MD, Ravi K. Ghanta, MD

    Published 2024-02-01
    Get full text
    Article
  7. 7
    Socioeconomic disparities in procedural choice and outcomes after aortic valve replacementCentral MessagePerspective

    Socioeconomic disparities in procedural choice and outcomes after aortic valve replacementCentral MessagePerspective by Paige E. Brlecic, MD, Katie J. Hogan, BS, John A. Treffalls, BS, Christopher B. Sylvester, PhD, Joseph S. Coselli, MD, Marc R. Moon, MD, Todd K. Rosengart, MD, Subhasis Chatterjee, MD, Ravi K. Ghanta, MD

    Published 2023-12-01
    Get full text
    Article
  8. 8
    Impact of frailty on outcomes and readmissions after transcatheter and surgical aortic valve replacement in a national cohortCentral MessagePerspective

    Impact of frailty on outcomes and readmissions after transcatheter and surgical aortic valve replacement in a national cohortCentral MessagePerspective by Travis J. Miles, MD, Christopher T. Ryan, MD, Katie J. Hogan, PhD, Bhavesh S. Sayal, BS, Christopher B. Sylvester, MD, PhD, Todd K. Rosengart, MD, Joseph S. Coselli, MD, Marc R. Moon, MD, Ravi K. Ghanta, MD, Subhasis Chatterjee, MD

    Published 2024-08-01
    Get full text
    Article
  9. 9
    Nationwide database analysis of one-year readmission rates after open surgical or thoracic endovascular repair of Stanford Type B aortic dissectionCentral MessagePerspective

    Nationwide database analysis of one-year readmission rates after open surgical or thoracic endovascular repair of Stanford Type B aortic dissectionCentral MessagePerspective by John A. Treffalls, BS, Christopher B. Sylvester, PhD, Umang Parikh, MD, Rodrigo Zea-Vera, MD, Christopher T. Ryan, MD, Qianzi Zhang, MS, Todd K. Rosengart, MD, Matthew J. Wall, MD, Joseph S. Coselli, MD, Subhasis Chatterjee, MD, Ravi K. Ghanta, MD

    Published 2022-09-01
    Get full text
    Article
  10. 10
    Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity

    Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity by Lynn A. C. Devilée, Abou bakr M. Salama, Jessica M. Miller, Janice D. Reid, Qinghui Ou, Nourhan M. Baraka, Kamal Abou Farraj, Madiha Jamal, Yibing Nong, Todd K. Rosengart, Douglas Andres, Jonathan Satin, Tamer M. A. Mohamed, James E. Hudson, Riham R. E. Abouleisa

    Published 2025-01-01
    Get full text
    Article
  11. 11
    Coronary artery bypass grafting at safety-net versus non–safety-net hospitalsCentral MessagePerspective

    Coronary artery bypass grafting at safety-net versus non–safety-net hospitalsCentral MessagePerspective by William C. Frankel, MD, Christopher B. Sylvester, PhD, Sainath Asokan, MS, Christopher T. Ryan, MD, Rodrigo Zea-Vera, MD, Qianzi Zhang, MPH, Matthew J. Wall, Jr, MD, Sandeep Markan, MD, Joseph S. Coselli, MD, Todd K. Rosengart, MD, Subhasis Chatterjee, MD, Ravi K. Ghanta, MD

    Published 2023-03-01
    Get full text
    Article

Search Tools: